JPMorgan Downgrades AMAG Pharmaceuticals (AMAG) to Neutral
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JPMorgan downgraded AMAG Pharmaceuticals (NASDAQ: AMAG) from Overweight to Neutral. PT lowered from $28 to $20.
For more ratings news on AMAG Pharmaceuticals click here and for the rating history of AMAG Pharmaceuticals click here.
Shares of AMAG Pharmaceuticals closed at $17.80 yesterday.
For more ratings news on AMAG Pharmaceuticals click here and for the rating history of AMAG Pharmaceuticals click here.
Shares of AMAG Pharmaceuticals closed at $17.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
